Portner-Helfer, M. (2013). Non solo i giovani finiscono all'ospedale per intossicazione alcolica. Losanna: Dipendenze Svizzera.
Abstract: Nel 2010 sono state circa 27’000 le persone curate negli ospedali svizzeri per alcoldipendenza o intossicazione alcolica: due patologie la cui frequenza aumenta con l’avanzare dell’età. Su incarico dell’Ufficio federale della sanità pubblica, Dipendenze Svizzera ha preso in esame i ricoveri dovuti all’alcol tra il 2003 e il 2010, evidenziando la percentuale di adolescenti e giovani adulti coinvolti, ma anche quella delle altre fasce d’età.
Keywords: AOD use, abuse, and dependence; alcohol poisoning; AODR violence; AOD use as accident factor; adolescent; young adult; adult; elderly; old age; prevention; counseling; statistical data; Switzerland; press release
|
Bischof, G. (2016). Rolle der Partnerschaft bei Rückfällen. SuchtMagazin, 42(1), 19–22.
Abstract: Neben personalen Faktoren und Merkmalen des Suchtmittels beeinflussen Umweltfaktoren – insbesondere das soziale Umfeld – Suchtentstehung und -verläufe. Umgekehrt haben Suchterkrankungen auch gravierende Auswirkungen auf Angehörige. Trotz dieser dokumentierten Wechselwirkungen ist die Forschungslage unzureichend. Der Beitrag gibt einen Überblick zu den Auswirkungen von Suchterkrankungen auf das soziale Umfeld und zum Stand der Forschung zu Einflussfaktoren des sozialen Nahfeldes auf Rückfälle. Entsprechend der Forschungslage stehen insbesondere PartnerInnen im Fokus des Beitrags. Implikationen für Forschung und Versorgung werden diskutiert.
Keywords: AOD use, abuse and dependence; relapse; spouse of AOD user; family; AODR interpersonal and societal problems; research
|
Maier, L. J., Bücheli, A., & Bachmann, A. (2013). Stimulanzienkonsum im Nachtleben. SuchtMagazin, 39(3; 06/2013), 15–20.
Abstract: Neben Alkohol, Tabak und Cannabis gehören Stimulanzien zu den meist konsumierten psychoaktiven Substanzen im Nachtleben. Die Auswertung von Daten zu Freizeitdrogenkonsumierenden, die im Rahmen von Schweizer Nightlife-Präventionsangeboten sowie Drug Checking erhoben worden sind, zeigen, dass der Konsum von Kokain, Amphetamin und Ecstasy sowie der Mischkonsum mit Alkohol für einen beträchtlichen Teil der Befragten zu einer typischen Partynacht dazugehören. Substanzspezifische Risiken, Zusammensetzungen illegaler Stimulanzien und riskante Konsummuster stellen bedeutsame Faktoren für die Gesundheit der Konsumierenden dar.
Keywords: stimulants; psychoactive substances; nightlife; AOD user; alcohol; cocaine in any form; amphetamines; ecstasy; risk factors; health; prevention; Switzerland
|
Addiction Info Suisse. (2010). Surfer sur le Net. Lausanne: Author.
Abstract: Naviguer sur Internet, chatter, jouer et participer à des forums c’est cool et ça passe le temps. Ça peut même être très enrichissant. La plupart des gens consacrent une partie de leur temps à l’ordi, sans que cela ne pose problème. Mais, comme pour tout, le risque d’exagérer existe!
Keywords: AOD use, abuse, and dependence; nonchemical addiction; internet; target group; adolescent; child; Switzerland
|
Dipendenze Info Svizzera. (2010). Navigare in rete. Losanna: Author.
Abstract: Navigare in Internet, chattare, giocare o partecipare ai forum sono attività divertenti che possono anche arricchire. Molte persone dedicano il proprio tempo libero al computer senza problemi. Tuttavia, come per tutto, c’é il rischio di esagerare.
Keywords: AOD use, abuse, and dependence; nonchemical addiction; internet; target group; adolescent; child; Switzerland
|
anonymous. (2005). Results of 8 years Dutch substance abuse treatment redesign : fact-sheets. Amersfoort: Geestelijke Gezondheidszorg (GGZ Nederland).
Abstract: National program “Scoring Results” produced new evidence based interventions, protocols and guidelines on treatment and prevention.
Keywords: treatment and maintenance; prevention; Netherlands
|
European Monitoring Centre for Drugs and Drug Addiction, & Inter-American Drug Abuse Control Commission of the Organization of American States. (2010). Building a national drugs observatory : a joint handbook. Joint publications. Luxembourg: Office for Official Publications of the European Communities.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Observatoire européen des drogues et des toxicomanies, & Commission interaméricaine de lutte contre l'abus des drogues de l'Organisation des États américains (Eds.). (2010). Création d'un observatoire national des drogues : manuel conjoint. Joint publications. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Falcato, L. (2013). Eine Reise nach Genf – Tagungsbericht zur 3. NaSuKo. SuchtMagazin, 39(1; 02/2013), 7–10.
Abstract: Namhafte ReferentInnen zeichneten an der Nationalen und Internationalen Substitutionskonferenz NaSuKo die Herausforderungen in der Drogenpolitik der letzten 25 Jahre nach und zeigten aus eigener Erfahrung auf, wie sie erfolgreich bewältigt werden konnten. Es wurde diskutiert, wie diese Errungenschaften angesichts eines im Drogenbereich bevorstehenden Generationenwechsels bewahrt werden können und aktuelle Themen besprochen: die gegenwärtige internationale wissenschaftliche Evidenz ebenso wie ethische Aspekte und offene Fragen im Zusammenhang mit der Behandlung von Störungen durch Opioide und andere Substanzen.
Keywords: AOD use, abuse, and dependence; opioids in any form; treatment and maintenance; government and politics; AOD public policy strategy; conference; Switzerland
|
various. (1990). Nemexin (Naltrexon HCl) : der Weg zurück. Glattbrugg: OpoPharma.
Abstract: Naltrexone – an effective aid in the psychosocial rehabilitation process of former opiate dependent patients [Article in German] Ladewig D Naltrexon is an longterm opioid antagonist, which can be used in the psychosocial rehabilitation process of former dependents on opiates. It was established that there were less opiates used during the treatment with Naltrexon. The exclusive delivery of Naltrexon cannot protect from relapse and has to be completed with psychotherapeutic measures. Naltrexone. Kleber HD Naltrexone (Trexan R), a long acting, orally affective narcotic antagonist was approved by the Food & Drug Administration in November, 1984 for use as an adjunct in the treatment of Opioid Addiction. This research capsule will explore what is known about naltrexone, and the most appropriate ways of using the drug. Naltrexone treatment in a jail work-release program. Brahen LS, Henderson RK, Capone T, Kordal N. Inmates with a history of opiate addiction have traditionally been excluded from jail work-release programs because of their high likelihood of returning to drug use. In 1972, a new jail work-release program was begun in the Nassau County (New York) Jail, to which addicted inmates, who had formerly been excluded automatically, could request admission if they took the opiate blocking agent naltrexone. Inmates received naltrexone twice a week and had routine urine checks for drugs of abuse and an alcohol breath test when indicated. Psychological and vocational testing and weekly psychotherapy sessions were provided. For those no longer incarcerated, the adjacent hospital outpatient clinic was available for naltrexone treatment. Naltrexone has proved to be a completely effective opiate blocking agent with no major side effects in 691 patients over a 10-year period.
Keywords: treatment and maintenance
|
